| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $179.5M | +3.6% | +10.8% |
| Cost of Revenue | $69.4M | +6.8% | +10.9% |
| R&D Expense | $20.2M | -6.4% | -0.3% |
| SG&A Expense | $24.6M | +9.0% | +0.2% |
| Operating Income | $25.0M | +14.0% | +65.6% |
| Interest Expense | $7.9M | +1.3% | -24.9% |
| Pre-tax Income | $20.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $482.1M | +13.2% | +24.5% |
| Accounts Receivable | $1.22B | -6.7% | +4.4% |
| Current Assets | $1.73B | -1.8% | +9.7% |
| Total Assets | $2.92B | -0.2% | +6.7% |
| Current Liabilities | $1.71B | -2.9% | +21.2% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $107.7M | — | — |
| Capital Expenditures | $45.1M | — | — |
| Investing Cash Flow | -$63.7M | — | — |
| Financing Cash Flow | -$47.0M | — | — |
| Free Cash Flow | $62.6M | — | — |
| +73.1% |
| +235.5% |
| Income Tax | $885K | -7.6% | -14.0% |
| Net Income | $20.1M | +80.1% | +284.7% |
| EPS (Basic) | $0.14 | +75.0% | +250.0% |
| EPS (Diluted) | $0.13 | +62.5% | +225.0% |
| $556.3M |
| -0.0% |
| +0.4% |
| Total Liabilities | $2.11B | -2.1% | +5.0% |
| Stockholders' Equity | $808.0M | +5.1% | +11.3% |